Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
- Figures corrected afterwards (2022).
Revenue
€ 13.8 million
▼ 2% vs 2024
Profit
Growing€ 17,778
▲ 107% vs 2024
Debts
Normal€ 8.6 million
▼ 12% vs 2024
OXYCURE from Fernelmont, company number BE0463450459, closed financial year 2025 with a result of € 17,778 after tax. For that financial year OXYCURE recorded revenue of € 13.8 million and equity of € 2.4 million. Compared with financial year 2024, the result moved from € -258,232 to € 17,778. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 29, 2026.
What happened at OXYCURE?
What happened at OXYCURE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- FRANCIS THOMAS stepped down as director. NBB
- CHANTAL HARDY stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 17,778. Source: NBB ↗
- FRANCIS THOMAS became a director. NBB
- CHANTAL HARDY became a director. NBB
- New establishment in Fernelmont. KBO
- Start of the company according to the CBE. KBO
In short
From € 466,800 loss in 2022 to € 17,778 profit in 2025.
Paid € 110,490 in corporate taxes since 2022.
Best year ever: 2025, with € 17,778 profit.
On average € 105,600 of value added per employee in 2023.
A new publication or filing at OXYCURE? We notify you, reason included.
Follow OXYCURENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by FRANCIS THOMAS (50%) and CHANTAL HARDY (50%).
Directors
According to the 2025 annual accounts
FRANCIS THOMAS
Director
since 2023 · until 2029
CHANTAL HARDY
Director
since 2023 · until 2029
Shareholders
FRANCIS THOMAS
50%
CHANTAL HARDY
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Léopold Genicot, ZI, Nov. 9
5380 Fernelmont
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
OVH, FR
DNS
Cloudflare DNS
Website info
Features
Security
Details
- Company number
- 0463.450.459
- VAT number
- BE 0463.450.459
- Registered office
- Rue Léopold Genicot, ZI, Nov. 9, 5380 Fernelmont
- Names & denominations
- OXYCURE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 May 1998
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- oxycure.be
- Activities · NACE
Activiteiten op het gebied van voeding
Detailhandel in farmaceutische producten
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige menselijke gezondheidszorg, n.e.g.
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en lease van medisch en paramedisch materieel
Vervaardiging van geneesmiddelen
Groothandel in farmaceutische en medische artikelen
+3